Plastic additive 14
USP/1545056 - United States Pharmacopeia (USP) Reference Standard
Synonym: Bis(2-ethylhexyl) phthalate; DEHP; Phthalic acid bis(2-ethylhexyl ester); ‘Dioctyl’ phthalate
CAS Number: 117-81-7
Empirical Formula (Hill Notation): C24H38O4
Molecular Weight: 390.56
MDL Number: MFCD00009493
Linear Formula: C24H38O4
Product Type: Chemical
| application(s) | USP Biologics pharmaceutical (small molecule) |
| bp | 386 °C (lit.) |
| density | 0.985 g/mL at 20 °C (lit.) |
| form | oil |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C24H38O4/c1-5-9-13-19( |
| InChI key | BJQHLKABXJIVAM-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | CCCCC(CC)COC(=O)c1ccccc1C |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Plastic additive 14 USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
| General description: | Plastic additive 14 is used in biologic packaging to improve the mechanical properties of polymers, enhancing flexibility and durability. As a USP reference standard, it supports the stability and safety of biologic products, ensuring that they remain effective and intact during transport and storage, meeting strict regulatory requirements. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| General description: | This compound is listed in the SVHC (Substances of very high concern) candidate list   of ECHA (European Chemicals Agency) |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This compound is listed in the SVHC (Substances of very high concern) candidate list of ECHA (European Chemicals Agency)This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
| Other Notes: | This product is part of USP Biologics Program. |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pha |
| Symbol |  GHS08 |
| Signal word | Danger |
| Hazard statements | H360FD |
| Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | 392.0 °F - Pensky-Martens c |
| Flash Point(C) | 200 °C - Pensky-Martens clo |
| bp | 386 °C (lit.) |
| Density | 0.985 g/mL at 20 °C (lit.) |
| UNSPSC | 41116107 |